TRUE Private Wealth Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-50
Closed -$5K 760
2020
Q4
$5K Hold
50
﹤0.01% 612
2020
Q3
$4K Hold
50
﹤0.01% 592
2020
Q2
$6K Sell
50
-15
-23% -$1.7K ﹤0.01% 550
2020
Q1
$5K Hold
65
﹤0.01% 532
2019
Q4
$6K Buy
+65
New +$7.29K ﹤0.01% 663
2019
Q3
Sell
-78
Closed -$13K 795
2019
Q2
$13K Buy
+78
New +$13.5K ﹤0.01% 519
2018
Q4
Sell
-124
Closed -$21.4K 1011
2018
Q3
$21.4K Buy
+124
New +$17.9K ﹤0.01% 593

Other funds holding GWPH

TRUE Private Wealth Advisors's GWPH Position: Q1 2021 in Review

TRUE Private Wealth Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 50 shares — an estimated $5K sold.

TRUE Private Wealth Advisors first reported a position in GWPH in Q3 2018 and held it in 7 quarters. The position peaked at $21.4K in Q3 2018. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • TRUE Private Wealth Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 50 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $5K.
  • TRUE Private Wealth Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 7 quarters.
  • TRUE Private Wealth Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $21.4K in Q3 2018.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.